CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 1186505-1186638 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T39147","span":{"begin":0,"end":133},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The main goal of the project is to assess the neuroprotective effects of MTA in models on MS, Parkinson disease, stroke and Epilepsy."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T11","span":{"begin":0,"end":133},"obj":"Sentence"}],"text":"The main goal of the project is to assess the neuroprotective effects of MTA in models on MS, Parkinson disease, stroke and Epilepsy."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T510","span":{"begin":94,"end":103},"obj":"Phenotype"},{"id":"T511","span":{"begin":113,"end":119},"obj":"Phenotype"},{"id":"T512","span":{"begin":124,"end":132},"obj":"Phenotype"}],"attributes":[{"id":"A510","pred":"hp_id","subj":"T510","obj":"http://purl.obolibrary.org/obo/HP_0001300"},{"id":"A511","pred":"hp_id","subj":"T511","obj":"http://purl.obolibrary.org/obo/HP_0001297"},{"id":"A512","pred":"hp_id","subj":"T512","obj":"http://purl.obolibrary.org/obo/HP_0001250"}],"text":"The main goal of the project is to assess the neuroprotective effects of MTA in models on MS, Parkinson disease, stroke and Epilepsy."}

    CORD-19-PD-UBERON

    {"project":"CORD-19-PD-UBERON","denotations":[{"id":"T4869","span":{"begin":90,"end":92},"obj":"Body_part"}],"attributes":[{"id":"A4869","pred":"uberon_id","subj":"T4869","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"}],"text":"The main goal of the project is to assess the neuroprotective effects of MTA in models on MS, Parkinson disease, stroke and Epilepsy."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1286","span":{"begin":90,"end":92},"obj":"Disease"},{"id":"T1287","span":{"begin":94,"end":111},"obj":"Disease"},{"id":"T1288","span":{"begin":113,"end":119},"obj":"Disease"},{"id":"T1290","span":{"begin":124,"end":132},"obj":"Disease"},{"id":"T67110","span":{"begin":90,"end":92},"obj":"Disease"},{"id":"T47036","span":{"begin":94,"end":111},"obj":"Disease"},{"id":"T63356","span":{"begin":113,"end":119},"obj":"Disease"},{"id":"T47332","span":{"begin":124,"end":132},"obj":"Disease"}],"attributes":[{"id":"A1286","pred":"mondo_id","subj":"T1286","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A1287","pred":"mondo_id","subj":"T1287","obj":"http://purl.obolibrary.org/obo/MONDO_0005180"},{"id":"A1288","pred":"mondo_id","subj":"T1288","obj":"http://purl.obolibrary.org/obo/MONDO_0005098"},{"id":"A1289","pred":"mondo_id","subj":"T1288","obj":"http://purl.obolibrary.org/obo/MONDO_0011057"},{"id":"A1290","pred":"mondo_id","subj":"T1290","obj":"http://purl.obolibrary.org/obo/MONDO_0005027"},{"id":"A13325","pred":"mondo_id","subj":"T67110","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A74775","pred":"mondo_id","subj":"T47036","obj":"http://purl.obolibrary.org/obo/MONDO_0005180"},{"id":"A59497","pred":"mondo_id","subj":"T63356","obj":"http://purl.obolibrary.org/obo/MONDO_0005098"},{"id":"A28394","pred":"mondo_id","subj":"T63356","obj":"http://purl.obolibrary.org/obo/MONDO_0011057"},{"id":"A75400","pred":"mondo_id","subj":"T47332","obj":"http://purl.obolibrary.org/obo/MONDO_0005027"}],"text":"The main goal of the project is to assess the neuroprotective effects of MTA in models on MS, Parkinson disease, stroke and Epilepsy."}